ðə dᵻklˈaɪn ɪn sˌiːdˈiː fˈoːɹ plˈʌs tˈiːsˈɛlz ɪn pˈeɪʃənts wɪð ˌaɪsˌiːˈɛl ɪz dʒˈɛnɚɹəli slˈoʊɚ ðɐn ðæt sˈiːn ɪn ˌeɪtʃˌaɪvˈiːɪnfˈɛktᵻd pˈeɪʃənts.
The decline in CD4+ T-cells in patients with ICL is generally slower than that seen in HIV-infected patients.